Berman Capital Advisors, LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 201 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.

Quarter-by-quarter ownership
Berman Capital Advisors, LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$3,000
-50.0%
362
-30.4%
0.00%
-100.0%
Q2 2021$6,000
+50.0%
520
+43.6%
0.00%0.0%
Q1 2021$4,000
-20.0%
3620.0%0.00%0.0%
Q4 2020$5,000
+66.7%
3620.0%0.00%0.0%
Q3 2020$3,0000.0%3620.0%0.00%0.0%
Q2 2020$3,000
+50.0%
3620.0%0.00%0.0%
Q1 2020$2,0003620.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Alexandria Capital, LLC 1,003,725$15,663,0001.66%
Golden State Equity Partners 123,817$1,932,0001.33%
Rhenman & Partners Asset Management AB 821,888$12,826,0001.05%
WASATCH ADVISORS LP 10,072,381$157,180,0000.77%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 29,636$462,0000.73%
Ceeto Capital Group, LLC 80,000$1,248,0000.63%
EMC Capital Management 48,992$765,0000.58%
Fort Sheridan Advisors LLC 71,173$1,111,0000.54%
Vanguard Capital Wealth Advisors 34,680$584,0000.54%
Casdin Capital, LLC 1,080,000$16,853,0000.50%
View complete list of SANGAMO THERAPEUTICS INC shareholders